Article Details
Retrieved on: 2025-05-24 12:48:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
William Blair restated a "market perform" rating on shares of Vigil Neuroscience in a research report on Thursday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here